Ignite Creation Date:
2024-05-06 @ 7:29 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06022003
Status:
RECRUITING
Last Update Posted:
2024-02-06
First Post:
2023-08-28
Brief Title:
Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects 18 Years of Age With RelapsedRefractory FLT3-mutated Acute Myeloid Leukemia
Sponsor:
French Innovative Leukemia Organisation
Organization:
French Innovative Leukemia Organisation
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-13
Start Date Type:
ACTUAL
Primary Completion Date:
2025-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-04
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-28
First Submit QC Date:
August 28 2023
Study First Post Date:
2023-09-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-05
Last Update Post Date:
2024-02-06
Last Update Post Date Type:
ACTUAL